Is there a generic for Korlym?
mifepristone tablet;oral Ask your health care provider for advice if you are unsure about the online purchase of any medication. See also: Generic Drug FAQ.
How long does it take for Korlym to work?
60% of patients had a 25% or greater reduction in blood sugar, with improvement seen as early as 6 weeks after initial treatment. A 1.1% reduction in HbA1c was seen by week 24 of treatment.
What are the side effects of Korlym?
The most common side effects of Korlym include:
- Nausea.
- Fatigue.
- Vomiting.
- Decreased appetite.
- Pain in your arms and legs (arthralgia)
- Swelling of your arms and legs. (peripheral edema)
- Headache.
- Dizziness.
How do you get to Korlym?
Please note: You can only get Korlym from 1 specialty pharmacy. Your SPARK pharmacist is available 24 hours a day, 7 days a week.
How long do you take korlym?
Dosing & Monitoring
- The recommended starting dose of Korlym is 300 mg/day1
- The dose may be increased by 300 mg (to a maximum of 1200 mg daily) every 2 to 4 weeks as needed.
Who manufactures korlym?
Corcept Therapeutics, a Silicon Valley-based drug company, began marketing Korlym six years ago as a specialty drug for about 10,000 rare-disease patients such as Edwin.
How long do you take Korlym?
What does Korlym treat?
Korlym® (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery.
How do I use Korlym?
Korlym® should always be taken as a single daily dose and with a meal. You should swallow the tablet whole and should not split, crush, or chew tablets.
Who makes korlym?
What is the half-life of korlym?
Time to steady state is within 2 weeks, and the mean (SD) half-life of the parent mifepristone was 85 (61) hours following multiple doses of 600 mg/day of KORLYM.
Is Korlym FDA approved?
Today, Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing’s syndrome.
When was korlym FDA approved?
Approval Date: 02/17/2012.
How does mifepristone work for Cushing’s disease?
Context: Mifepristone (RU 486) blocks the action of cortisol by binding to the glucocorticoid receptor and, therefore, is of potential therapeutic value in Cushing’s syndrome. However, research in endogenous hypercortisolism has been hampered by the controversy related to the use of mifepristone for inducing abortion.
Who makes Korlym?